Back

HBV S100 Prescriber Program Evaluation Summary

First published:

N/A

Last published:

N/A

Overview

An independent evaluation of ASHM’s HBV s100 Prescriber Program was conducted in 2018, covering the period 1 Jul 2015 – 31 December 2017. The evaluation was mixed-methods, comprising interviews with GP prescribers, specialists, government representatives, program partners and consumers (n=30), a survey of GP prescribers (n=135), as well as a review of program data and analysis of population-level data. A summary of the results of the evaluation is presented here.

Suggested Professions

This is not an extensive list of professions, and other practitioners might benefit from this resource

Resource information not available